SLC2A1 and psoriasis: In addition, (topical) pharmacological inhibition of GLUT1 could block inflammatory gene expression and significantly suppress inflammatory infiltration and cytokine secretion in skin biopsies from psoriasis patients, suggesting that infiltrating lymphocytes can also be targeted (Zhang et al., 2018; Cibrian et al., 2020a).